There are new details in Sharapova’s Meldonium gate

There are new details in a notorious case of tennis player Maria Sharapova related to Mildronate

It became known, when exactly it held a hearing in court. The servants of Themis will find out details of the case on May 18 in London. Recall that in early spring athlete released information about a finding Meldonium in analysis.

Mildronate is banned by the World Anti-Doping Agency (WADA) from January 1, 2016. Sharapova was unable to take part in competitions, starting from 12 March. Experts say that the maximum penalty for an athlete to use this material - suspension from games for four years. Disqualification shall enter into force immediately after Sharapova dismissal from employment. All the parties may appeal the decision within three weeks from the date of its notification.

As reported, "URA-Inform", recently the President of the Russian Federation asked how he manages to stay in good physical shape. To which Putin replied. "No Meldonium. Absolutely."

Maria Yuryevna Sharapova is a Russian professional tennis player, who is ranked world No. 9 by theWomen's Tennis Association (WTA). A United States resident since 1994, Sharapova has competed on the WTA tour since 2001. She has been ranked world No. 1 in singles by the WTA on five separate occasions, for a total of 21 weeks. She is one of ten women, and the only Russian, to hold the career Grand Slam. She is also an Olympic medalist, having earned silver for Russia in women's singles at the 2012 Summer Olympics in London.

In March 2016, Sharapova revealed she had failed a drug test at the 2016 Australian Open, admitting to testing positive for meldonium, a substance banned by the World Anti-Doping Agency (WADA) at the start of 2016, and was provisionally suspended from playing tennis by the International Tennis Federation (ITF)